COMMUNIQUÉ DE PRESSE publié le 06/03/2025 à 07:00, il y a 1 année 7 mois Siltronic demonstrates resilience in the financial year 2024 – Muted expectations for 2025 due to continued high inventory levels Siltronic AG demonstrates resilience in 2024 with sales of EUR 1,412.8 million and EBITDA of EUR 363.8 million. Muted 2025 expectations due to high inventory levels. Insights into financial performance and outlook Financial Results 2024 Siltronic AG Résilience 2025
COMMUNIQUÉ DE PRESSE publié le 06/03/2025 à 07:00, il y a 1 année 7 mois Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
COMMUNIQUÉ DE PRESSE publié le 06/03/2025 à 07:00, il y a 1 année 7 mois Cicor continues to grow – sales and profits at record levels thanks to strategic expansion Cicor Technologies Ltd reports record sales and profits in 2024, following strategic expansion. Earnings per share, free cash flow, and profit margins show significant growth, positioning the company for future success Financial Performance Record Sales Cicor Technologies Ltd Strategic Expansion Profits
COMMUNIQUÉ DE PRESSE publié le 06/03/2025 à 07:00, il y a 1 année 7 mois PALFINGER AG: PALFINGER records second-best financial year in 2024 and gives positive outlook for 2025 PALFINGER AG reports second-best financial year in 2024 with revenue of EUR 2.36 billion and positive outlook for 2025, targeting significant increase in turnover and profitability until 2027 Revenue Profitability Financial Year Outlook PALFINGER AG
COMMUNIQUÉ DE PRESSE publié le 06/03/2025 à 07:00, il y a 1 année 7 mois Evolva Holding SA publishes agenda for Annual General Meeting 2025 Evolva Holding SA publishes agenda for Annual General Meeting 2025, including M&A activities and proposals by Clearway Capital Partners ICAV Board Of Directors Annual General Meeting M&A Activities Evolva Holding SA Clearway Capital Partners
COMMUNIQUÉ DE PRESSE publié le 06/03/2025 à 07:00, il y a 1 année 7 mois Zalando Sees Accelerating Growth This Year Following Strong 2024 Performance, Driven by Successful Execution of Ecosystem Strategy Zalando expects accelerated growth in 2025 after strong 2024 performance, focusing on ecosystem strategy. GMV, revenue, and EBIT projections announced Financial Performance Strategy Growth 2025 Zalando
COMMUNIQUÉ RÉGLEMENTÉ publié le 06/03/2025 à 07:00, il y a 1 année 7 mois EURAZEO RÉALISE UNE PREMIÈRE ANNÉE DYNAMIQUE DANS L’EXÉCUTION DE SON PLAN STRATÉGIQUE 2024-2027
COMMUNIQUÉ RÉGLEMENTÉ publié le 06/03/2025 à 07:00, il y a 1 année 7 mois EURAZEO PERFORMS STRONGLY IN THE FIRST YEAR OF ITS 2024-2027 STRATEGIC PLAN Eurazeo performs strongly in the first year of its 2024-2027 strategic plan, showing robust asset management momentum, sharp rise in realizations and deployments, and value creation despite impairment of legacy assets Financial Results EURAZEO Asset Management Strategic Plan Value Creation
COMMUNIQUÉ RÉGLEMENTÉ publié le 06/03/2025 à 07:00, il y a 1 année 7 mois Biophytis annonce sa participation à la conférence BIO-Europe Spring à Milan Biophytis annonce sa participation à la conférence BIO-Europe Spring à Milan pour discuter de son principal candidat médicament, BIO101, dans l'obésité et la sarcopénie Biophytis Conference BIO-Europe Spring Sarcopénie Obésité
COMMUNIQUÉ RÉGLEMENTÉ publié le 06/03/2025 à 07:00, il y a 1 année 7 mois Biophytis announces its participation to the BIO-Europe Spring 2025 in Milan Biophytis announces participation in BIO-Europe Spring 2025 in Milan. Chief Business Officer to attend meetings. Focus on lead drug candidate BIO101 in obesity and sarcopenia Biophytis Sarcopenia BIO101 Obesity BIO-Europe Spring 2025
Publié le 02/11/2026 à 18:01, il y a 16 minutes Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Publié le 02/11/2026 à 18:00, il y a 17 minutes Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Publié le 02/11/2026 à 18:00, il y a 17 minutes Covivio - Information on total number of voting rights and share capital
Publié le 02/11/2026 à 17:59, il y a 18 minutes Saint-Gobain finalise la cession de ses activités Dahl de distribution spécialisée en Suède, en Norvège et au Danemark
Publié le 02/11/2026 à 17:59, il y a 18 minutes Saint-Gobain completes the divestment of its Dahl specialist distribution business in Sweden, Norway and Denmark
Publié le 02/11/2026 à 17:00, il y a 1 heure 17 minutes PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Publié le 02/11/2026 à 17:00, il y a 1 heure 17 minutes QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
Publié le 02/11/2026 à 16:15, il y a 2 heures 2 minutes ACCESS Newswire Launches SPOT, Seven AI Agents That Check Every Press Release Before Submission
Publié le 02/11/2026 à 15:00, il y a 3 heures 17 minutes CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Publié le 02/11/2026 à 14:00, il y a 4 heures 17 minutes GameSquare to Report Q3 2026 Financial Results on November 16, 2026
Publié le 02/11/2026 à 18:00, il y a 17 minutes Helvetia Asset Management SA adopte une présence unifiée sur le marché
Publié le 02/11/2026 à 18:00, il y a 17 minutes Helvetia Asset Management Ltd adopts a unified market presence
Publié le 02/11/2026 à 17:40, il y a 37 minutes VALBIOTIS SA: Valbiotis delivers a first order to its Chinese joint venture and targets a commercial launch in China by the end of 2026
Publié le 02/11/2026 à 17:40, il y a 37 minutes VALBIOTIS SA: Valbiotis livre une première commande à sa coentreprise chinoise et vise un lancement commercial en Chine d’ici la fin de l’année 2026